CHAM
DMK

Clear Harbor Asset Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Clear Harbor Asset Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14
Closed -$783 – 764
2020
Q3 		$783 Buy
+14
New +$830 ﹤0.01% 769
2020
Q1 		– Sell
-14
Closed -$700 – 736
2019
Q4 		$700 Buy
+14
New +$679 ﹤0.01% 773

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Harbor Asset Management's DMK Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2020, closing a stake of 14 shares — an estimated $783 sold.

Clear Harbor Asset Management first reported a position in DMK in Q4 2019 and held it in 2 quarters. The position peaked at $783 in Q3 2020. 41 funds tracked by Wall St. Rank hold DMK as of Q4 2020.

  • Clear Harbor Asset Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2020 after selling out during the quarter.
  • Clear Harbor Asset Management sold 14 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2020, an estimated $783.
  • Clear Harbor Asset Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2019 and held it in 2 quarters.
  • Clear Harbor Asset Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $783 in Q3 2020.
  • 41 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.